Showing 1 - 16 results of 16 for search 'Shailender Bhatia', query time: 0.04s
Refine Results
-
1
-
2
Immunotherapy for Merkel cell carcinoma: a turning point in patient care by Isaac S. Chan, Shailender Bhatia, Howard L. Kaufman, Evan J. Lipson
Published 2018-03-01
Article -
3
819 Concurrent treatment with GM-CSF immunoembolization of hepatic metastases and systemic immune checkpoint inhibitors to overcome immune evasion in patients with metastatic uveal... by Evan Hall, Shailender Bhatia, Joshua Veatch, Wayne Monsky, Natalie J Miller, Jacob Leary, William McCamy
Published 2023-11-01Article -
4
Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study by Shailender Bhatia, Paul Nghiem, Alejandro Vanegas, Kristina Lachance, Lisa Tachiki, Kevin Chiu, Emily Boller, Murtuza Bharmal, S Phani Veeranki
Published 2022-08-01
Article -
5
Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patients by Iuliia Kovalenko, Wern Lynn Ng, Yimin Geng, Yinghong Wang, Pavlos Msaouel, Shailender Bhatia, Petros Grivas, Raed Benkhadra, Omar Alhalabi
Published 2024-01-01
Article -
6
610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell... by Shailender Bhatia, Ramesh Rengan, Sylvia M Lee, Scott S Tykodi, Jing Zeng, Mary Redman, Peter H Goff, Kelsey K Baker
Published 2023-11-01Article -
7
-
8
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512. by Shailender Bhatia, James Moon, Kim A Margolin, Jeffrey S Weber, Christopher D Lao, Megan Othus, Ana M Aparicio, Antoni Ribas, Vernon K Sondak
Published 2012-01-01
Article -
9
-
10
-
11
Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review by Tomoko Akaike, Kelsey Cahill, Gensuke Akaike, Emily T. Huynh, Daniel S. Hippe, Michi M. Shinohara, Jay Liao, Smith Apisarnthanarax, Upendra Parvathaneni, Evan Hall, Shailender Bhatia, Richard K. Cheng, Paul Nghiem, Yolanda D. Tseng
Published 2022-11-01
Article -
12
Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy by Natalie J. Miller, Candice D. Church, Steven P. Fling, Rima Kulikauskas, Nirasha Ramchurren, Michi M. Shinohara, Harriet M. Kluger, Shailender Bhatia, Lisa Lundgren, Martin A. Cheever, Suzanne L. Topalian, Paul Nghiem
Published 2018-11-01
Article -
13
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial by Howard L. Kaufman, Jeffery S. Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden, Sandra P. D’Angelo, Kent C. Shih, Céleste Lebbé, Michele Milella, Isaac Brownell, Karl D. Lewis, Jochen H. Lorch, Anja von Heydebreck, Meliessa Hennessy, Paul Nghiem
Published 2018-01-01
Article -
14
Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance by Christopher W. Lewis, Jamiluddin Qazi, Daniel S. Hippe, Kristina Lachance, Hannah Thomas, Maclean M. Cook, Ilsa Juhlin, Neha Singh, Zoe Thuesmunn, Seesha R. Takagishi, Aubriana McEvoy, Coley Doolittle‐Amieva, Shailender Bhatia, Kelly G. Paulson, Ryan B. O'Malley, Carolyn L. Wang, Paul Nghiem
Published 2020-02-01
Article -
15
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer by Christopher A Barker, Evan J Lipson, Harriet Kluger, Brian R Gastman, Michael T Tetzlaff, Igor Puzanov, Shailender Bhatia, Paul Nghiem, Ann W Silk, Zeynep Eroglu, Sunandana Chandra, Isaac Brownell, Anna C Pavlick, David M Miller, Vernon K Sondak, Kari L Kendra, Kathryn B Bollin, Kathleen Madden, Guilherme Rabinowits, Emily S Ruiz, Edward A Tavss
Published 2022-07-01
Article -
16
1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial by David Geller, Ashley Moody, Richard Carvajal, Cara Haymaker, Sunil Reddy, Jose Lutzky, Shailender Bhatia, Diwakar Davar, Bartosz Chmielowski, Theresa Medina, Eric Wehrenberg-Klee, Marlana Orloff, Rahul Sheth, Sapna P Patel, Robert Knight, Jason Laporte, Prajna Guha, Bryan Cox, Steven Katz, Paula Novelli, Joshua D Kuban, Ann-Marie Hulstine, Kamaneh Montazeri, Shaheer A Khan, Lindsay Thornton, Anthony Lucci, Vanessa Sarli, Salyna Meas, Chandra C Ghosh
Published 2023-11-01Article